Nature Communications (Aug 2024)

Selective hydrogenation of nitro compounds to amines by coupled redox reactions over a heterogeneous biocatalyst

  • Daria Sokolova,
  • Tara C. Lurshay,
  • Jack S. Rowbotham,
  • Georgia Stonadge,
  • Holly A. Reeve,
  • Sarah E. Cleary,
  • Tim Sudmeier,
  • Kylie A. Vincent

DOI
https://doi.org/10.1038/s41467-024-51531-2
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 9

Abstract

Read online

Abstract Cleaner synthesis of amines remains a key challenge in organic chemistry because of their prevalence in pharmaceuticals, agrochemicals and synthetic building blocks. Here, we report a different paradigm for chemoselective hydrogenation of nitro compounds to amines, under mild, aqueous conditions. The hydrogenase enzyme releases electrons from H2 to a carbon black support which facilitates nitro-group reduction. For 30 nitroarenes we demonstrate full conversion (isolated yields 78 – 96%), with products including pharmaceuticals benzocaine, procainamide and mesalazine, and 4-aminophenol – precursor to paracetamol (acetaminophen). We also showcase gram-scale synthesis of procainamide with 90% isolated yield. We demonstrate potential for extension to aliphatic substrates. The catalyst is highly selective for reduction of the nitro group over other unsaturated bonds, tolerant to a wide range of functional groups, and exhibits excellent stability in reactions lasting up to 72 hours and full reusability over 5 cycles with a total turnover number over 1 million, indicating scope for direct translation to fine chemical manufacturing.